Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
Chr t(15;17)/PML-RARA fusion
i
Other names:
RARA, Retinoic Acid Receptor Alpha, Nuclear Receptor Subfamily 1 Group B Member 1, RAR-Alpha, NR1B1, Nucleophosmin-Retinoic Acid Receptor Alpha Fusion Protein NPM-RAR Long Form, Retinoic Acid Nuclear Receptor Alpha Variant 1, Retinoic Acid Nuclear Receptor Alpha Variant 2, Retinoic Acid Receptor, Alpha Polypeptide, Retinoic Acid Receptor, Alpha, RAR, PML, Promyelocytic Leukemia, Tripartite Motif-Containing Protein 19, Promyelocytic Leukemia Protein, RING Finger Protein 71, Protein PML, PP8675, T
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
55294
;
5914
;
5371
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
FBXW7 underexpression (2)
RARA overexpression (2)
FBXW7 overexpression (1)
RARA positive (1)
FBXW7 underexpression (2)
RARA overexpression (2)
FBXW7 overexpression (1)
RARA positive (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
Chr t(15;17)/PML-RARA fusion
Acute Myelogenous Leukemia
Chr t(15;17)/PML-RARA fusion
Acute Myelogenous Leukemia
venetoclax + ruxolitinib
Resistant: C3 – Early Trials
venetoclax + ruxolitinib
Resistant
:
C3
venetoclax + ruxolitinib
Resistant: C3 – Early Trials
venetoclax + ruxolitinib
Resistant
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.